Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Michael Saylor Teases More Bitcoin After Strategy’s $69.45B Reserve Hits 848,250 BTC
Key Takeaways: Bitcoin bull Michael Saylor suggested that Strategy will be buying another Bitcoin. Currently, Strategy has 848,250...
BitTorrent Ushers in Next-Gen Web3 Infrastructure with Strategic Rebrand and Inaugural BTT Burn
The first round of BTT repurchased with decentralized service revenue has been completely burned, as BitTorrent leverages its reim...
Cryptocurrencies like Hyperliquid, Zcash soar over 100% in 2026: Motley Fool
The surge in cryptocurrencies like Hyperliquid and Zcash in 2026 highlights growing investor confidence and potential market resil...
Strategy’s discretionary cash falls 72% as buyback authorization rises to $3 billion
Strategy's discretionary USD Cash fell to $447.3 million as the company spent another $193.1 million on STRC buybacks and raised i...
Strategy Keeps Buying: Third Purchase This Month Brings October Spending to $73 Million
Bitcoin Magazine Strategy Keeps Buying: Third Purchase This Month Brings October Spending to $73 Million The largest corporate hol...
Morpho sees record Bitcoin-backed borrowing on Base markets
The surge in Bitcoin-backed borrowing on Base highlights the growing integration of DeFi into mainstream finance, driven by platfo...